Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2023-2029

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2023-2029

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

LPI (LP Information)' newest research report, the “Single Nucleotide Polymorphism (SNP) Genotyping Industry Forecast” looks at past sales and reviews total world Single Nucleotide Polymorphism (SNP) Genotyping sales in 2022, providing a comprehensive analysis by region and market sector of projected Single Nucleotide Polymorphism (SNP) Genotyping sales for 2023 through 2029. With Single Nucleotide Polymorphism (SNP) Genotyping sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single Nucleotide Polymorphism (SNP) Genotyping industry.

This Insight Report provides a comprehensive analysis of the global Single Nucleotide Polymorphism (SNP) Genotyping landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Single Nucleotide Polymorphism (SNP) Genotyping portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Single Nucleotide Polymorphism (SNP) Genotyping market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single Nucleotide Polymorphism (SNP) Genotyping and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single Nucleotide Polymorphism (SNP) Genotyping.

The global Single Nucleotide Polymorphism (SNP) Genotyping market size is projected to grow from US$ 16530 million in 2022 to US$ 66080 million in 2029; it is expected to grow at a CAGR of 21.9% from 2023 to 2029.

Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%.

North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent.

In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Single Nucleotide Polymorphism (SNP) Genotyping market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Transversion

Transition

Segmentation by application

Diagnostics

Animal

Plant

Research

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Illumina

Affymetrix

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen

Luminex Corporation

Enzo Life Sciences

Bio-rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences

Please note: The report will take approximately 2 business days to prepare and deliver.